14-3-3tau drives estrogen receptor loss via ERalpha36 induction and GATA3 inhibition in breast cancer. Garan LAW, Xiao Y, Lin WC. Proc Natl Acad Sci U S A 2022;119:e2209211119.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Garan LAW, Xiao Y, Lin WC. 14-3-3tau drives estrogen receptor loss via ERalpha36 induction and GATA3 inhibition in breast cancer. Proc Natl Acad Sci U S A 2022;119:e2209211119.
PMID: 36252018